Major CRISPR errors were discovered by chance
By Katherine Lindemann,
Research Gate
| 07. 23. 2018
A study released last week suggests that the gene editing technology CRISPR-Cas9 may not be as precise as previously thought. Researchers found that in addition to small errors already known to be part of the gene editing process, CRISPR-Cas9 can cause large deletions and even rearrangements in genes around the target site.
The researchers looked at errors in mouse and human cells in lab conditions. In some cases, deletions were as large as several thousand DNA bases, enough to potentially alter the function of a cell. Whether the findings will affect CRISPR’s utility for clinical applications is not yet known. But researchers do expect increased scrutiny of the technology, and the scope of gene editing errors, going forward.
We spoke with one of the study’s authors, Michael Kosicki, to learn more about the discovery and its implications.
ResearchGate: What motivated this study?
Michael Kosicki: It was really serendipity. A control experiment for another study gave an unexpected result, and we decided to investigate. Initial results made it clear we were looking at something very exciting indeed, with implications for...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...